secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0000950170-25-082494
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenon Pharmaceuticals holds 2025 Annual Meeting; all director nominees elected
------------------------------------------------------------------------------

- All 8 director nominees elected with over 64M votes each; broker non-votes of 2.2M.
- Advisory say-on-pay passed with 67.3M for, 2.1M against, 0.5M abstain.
- Appointment of PricewaterhouseCoopers LLP as auditor approved (72.0M for, 34K withheld).
- Auditor remuneration authority approved (72.0M for, 25K against, 11K abstain).
- Approximately 94.1% of outstanding common shares voted at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000095017025082494/0000950170-25-082494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000095017025082494/xene-20250604.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-082494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer